J.-F. Geay

639 total citations
15 papers, 479 citations indexed

About

J.-F. Geay is a scholar working on Oncology, Reproductive Medicine and Surgery. According to data from OpenAlex, J.-F. Geay has authored 15 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Reproductive Medicine and 3 papers in Surgery. Recurrent topics in J.-F. Geay's work include Ovarian cancer diagnosis and treatment (6 papers), HER2/EGFR in Cancer Research (3 papers) and Intraperitoneal and Appendiceal Malignancies (3 papers). J.-F. Geay is often cited by papers focused on Ovarian cancer diagnosis and treatment (6 papers), HER2/EGFR in Cancer Research (3 papers) and Intraperitoneal and Appendiceal Malignancies (3 papers). J.-F. Geay collaborates with scholars based in France, Netherlands and Switzerland. J.-F. Geay's co-authors include Éric Pujade-Lauraine, B. Weber, J. Provençal, Gilles Freyer, Sandrine Touzet, G. Ganem, J.P. Jacquin, N. Tubiana-Mathieu, O. Gisserot and D. Paraïso and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

J.-F. Geay

14 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.-F. Geay France 6 200 176 169 147 106 15 479
J. Provençal France 5 86 0.4× 148 0.8× 169 1.0× 76 0.5× 106 1.0× 10 366
J.P. Jacquin France 8 62 0.3× 215 1.2× 211 1.2× 79 0.5× 209 2.0× 12 512
Jacques Cretin France 7 63 0.3× 171 1.0× 84 0.5× 57 0.4× 60 0.6× 9 328
Björn Penninckx United Kingdom 5 27 0.1× 160 0.9× 146 0.9× 72 0.5× 82 0.8× 7 378
L.F.A.G. Massuger Netherlands 11 183 0.9× 86 0.5× 36 0.2× 113 0.8× 84 0.8× 32 474
Margherita Fischetti Italy 14 268 1.3× 125 0.7× 18 0.1× 182 1.2× 15 0.1× 39 578
Philippe Rauch France 11 54 0.3× 294 1.7× 11 0.1× 273 1.9× 16 0.2× 22 563
M.J. Tennapel United States 12 9 0.0× 86 0.5× 76 0.4× 103 0.7× 133 1.3× 41 425
Vikaash Kumar Canada 8 27 0.1× 309 1.8× 21 0.1× 81 0.6× 62 0.6× 22 585
Romain Rivoirard France 11 34 0.2× 125 0.7× 13 0.1× 51 0.3× 15 0.1× 53 307

Countries citing papers authored by J.-F. Geay

Since Specialization
Citations

This map shows the geographic impact of J.-F. Geay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-F. Geay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-F. Geay more than expected).

Fields of papers citing papers by J.-F. Geay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-F. Geay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-F. Geay. The network helps show where J.-F. Geay may publish in the future.

Co-authorship network of co-authors of J.-F. Geay

This figure shows the co-authorship network connecting the top 25 collaborators of J.-F. Geay. A scholar is included among the top collaborators of J.-F. Geay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.-F. Geay. J.-F. Geay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bodegraven, Emma J. van, Elvira Infante, Florent Péglion, et al.. (2025). Intermediate filaments promote glioblastoma cell invasion by controlling nuclear deformations and mechanosensitive expression of MMP14. Cell Reports. 44(11). 116553–116553.
2.
Geay, J.-F., David Gentien, Fabien Reyal, et al.. (2024). Plakins are involved in the regulation of centrosome position in polarized epithelial cells. Biology of the Cell. 116(7). e2400048–e2400048. 1 indexed citations
3.
Rafii, Arash, Bruno Deval, J.-F. Geay, et al.. (2007). Treatment of FIGO stage IV ovarian carcinoma: results of primary surgery or interval surgery after neoadjuvant chemotherapy: a retrospective study. International Journal of Gynecological Cancer. 17(4). 777–783. 30 indexed citations
4.
Rafii, Arash, Bruno Deval, J.-F. Geay, et al.. (2007). Treatment of FIGO stage IV ovarian carcinoma: results of primary surgery or interval surgery after neoadjuvant chemotherapy: a retrospective study. International Journal of Gynecological Cancer. 17(4). 777–783. 2 indexed citations
5.
Ferrero, Jean-­Marc, B. Weber, J.-F. Geay, et al.. (2006). Second-line chemotherapy with pegylated liposomal doxorubicin and carboplatin is highly effective in patients with advanced ovarian cancer in late relapse: a GINECO phase II trial. Annals of Oncology. 18(2). 263–268. 86 indexed citations
6.
7.
Guastalla, Jean‐Paul, R. Largillier, J.-F. Geay, et al.. (2006). Docetaxel (Do) and liposomal pegylated doxorubicin in metastatic breast cancer (MBC) patients (pts): The French GINECO group experience. Journal of Clinical Oncology. 24(18_suppl). 10589–10589. 1 indexed citations
8.
Pujade-Lauraine, Éric, J.-F. Geay, & C. Topham. (2006). Traitement de l’anémie par injection hebdomadaire chez les patients atteints de cancer: analyse comparative des agents stimulants l’érythropoïèse. ONCOLOGIE. 8(5). 494–502. 1 indexed citations
9.
Geay, J.-F., Éric Pujade-Lauraine, & Jean Paul Guastalla. (2006). Chimiothérapie intrapéritonéale dans les cancers de l’ovaire. ONCOLOGIE. 8(2). 145–151. 3 indexed citations
10.
Pujade-Lauraine, Éric, J.-F. Geay, & C. Topham. (2006). Traitement de l’anémie par injection hebdomadaire chez les patients atteints de cancer: analyse comparative des agents stimulants l’érythropoïèse. ONCOLOGIE. 8(8). 790–790. 1 indexed citations
11.
Freyer, Gilles, M. Debled, J.-F. Geay, et al.. (2006). Celecoxib (Ce) + exemestane (Ex) versus placebo + Ex in post-menopausal (PM) metastatic breast cancer (MBC) patients (pts): A double-blind phase III GINECO study. Journal of Clinical Oncology. 24(18_suppl). 565–565. 5 indexed citations
12.
Freyer, Gilles, J.-F. Geay, Sandrine Touzet, et al.. (2005). Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study. Annals of Oncology. 16(11). 1795–1800. 251 indexed citations
13.
14.
Guastalla, Jean‐Paul, Anne‐Claire Hardy‐Bessard, J.-F. Geay, et al.. (2004). Phase I study of pegylated liposomal doxorubicin (CA) and docetaxel (T) bimonthly in the first-line treatment of metastatic breast cancer (MBC): The CAT regimen. Journal of Clinical Oncology. 22(14_suppl). 818–818. 1 indexed citations
15.
Guastalla, Jean‐Paul, Anne‐Claire Hardy‐Bessard, J.-F. Geay, et al.. (2004). Phase I study of pegylated liposomal doxorubicin (CA) and docetaxel (T) bimonthly in the first-line treatment of metastatic breast cancer (MBC): The CAT regimen. Journal of Clinical Oncology. 22(14_suppl). 818–818. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Provençal Breakdown of academic impact, for papers by J.P. Jacquin Breakdown of academic impact, for papers by Jacques Cretin Breakdown of academic impact, for papers by Björn Penninckx Breakdown of academic impact, for papers by L.F.A.G. Massuger Breakdown of academic impact, for papers by Margherita Fischetti Breakdown of academic impact, for papers by Philippe Rauch Breakdown of academic impact, for papers by M.J. Tennapel Breakdown of academic impact, for papers by Vikaash Kumar Breakdown of academic impact, for papers by Romain Rivoirard
Rankless by CCL
2026